TOI Q1 2026 Earnings Narrowing Losses Surprises Street Shares Edge Higher NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 AMBP Q1 2026 Earnings Strong EPS Beat Overshadowed by Market Headwinds GWRE Q1 2026 Earnings Strong EPS Beat Drives Stock Higher WU Q1 2026 Earnings EPS Falls Short of Estimates Stock Dips GRBK Q1 2026 Earnings Strong BottomLine Beat Despite Modest Stock Dip